Corebridge Financial’s bluebird bio BLUE Stock Holding History

Corebridge Financial’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-4,781	Closed	-$23.3K	–	386
2025 Q1	$23.3K	Sell	4,781 -72	-1%	-$433	﹤0.01%	2886
2024 Q4	$40.5K	Sell	4,853 -270	-5%	-$2.36K	﹤0.01%	2876
2024 Q3	$53.2K	Sell	5,123 -32	-0.6%	-$532	﹤0.01%	2854
2024 Q2	$101K	Buy	+5,155	New	+$103K	﹤0.01%	2598

Other funds holding BLUE

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Corebridge Financial's BLUE Position: Q2 2025 in Review

Corebridge Financial sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 4,781 shares — an estimated $23.3K sold.

Corebridge Financial first reported a position in BLUE in Q2 2024 and held it in 4 quarters. The position peaked at $101K in Q2 2024. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.

Corebridge Financial reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
Corebridge Financial sold 4,781 bluebird bio shares in Q2 2025, an estimated $23.3K.
Corebridge Financial first reported a position in bluebird bio in Q2 2024 and held it in 4 quarters.
Corebridge Financial's bluebird bio position peaked at $101K in Q2 2024.
3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.